These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 4190508)

  • 1. [On medical therapy of prostate hypertrophy with a synthetic progestational hormone. (Preliminary note)].
    Frizzi V
    Minerva Med; 1970 Feb; 61(15):694-9. PubMed ID: 4190508
    [No Abstract]   [Full Text] [Related]  

  • 2. Therapy with progestational agents in advanced benign prostatic hypertrophy.
    Geller J; Angrist A; Nakao K; Newman H
    JAMA; 1969 Nov; 210(8):1421-7. PubMed ID: 4187537
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies using synthetic progestogens in drug therapy of so-called prostatic hypertrophy].
    Scultéty S; Sas M; Varga B
    Z Urol Nephrol; 1973 Jan; 66(1):49-59. PubMed ID: 4121364
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of progestational agents on gonadal and adrenal cortical function in patients with benign prostatic hypertrophy and carcinoma of the prostate.
    Geller J; Fruchtman B; Meyer C; Newman H
    J Clin Endocrinol Metab; 1967 Apr; 27(4):556-60. PubMed ID: 4164338
    [No Abstract]   [Full Text] [Related]  

  • 5. [Conservative treatment of prostatic hypertrophy with gestagens].
    Baevskiĭ IuL
    Urol Nefrol (Mosk); 1974; 39(4):31-3. PubMed ID: 4137390
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of hypertrophy of the prostate with gestagens].
    Vahlensieck W; Gödde S
    Munch Med Wochenschr; 1968 Jun; 110(26):1573-7. PubMed ID: 4182927
    [No Abstract]   [Full Text] [Related]  

  • 7. [Results and considerations on several cases of prostatic hypertrophy treated with hydroxyprogesterone capronate].
    Tinunin O
    Minerva Urol; 1969; 21(4):107-20. PubMed ID: 4192306
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of benign prostatic hypertrophy with progestogens including gestonorone caproate].
    Nagel R; Hargenda B
    Hinyokika Kiyo; 1970 Sep; 16(9):423-8. PubMed ID: 4097356
    [No Abstract]   [Full Text] [Related]  

  • 9. [Progesterone drugs and adenoma of the prostate. Considerations on a 4-year trial].
    Steckelmacher P
    Acta Urol Belg; 1973 Jul; 41(3):462-4. PubMed ID: 4127420
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical and cysto-sphincterometric results of progestogen therapy of prostatic adenoma].
    Makrigiannis D; Gaca AH
    Clin Ter; 1971 Jun; 57(5):399-416. PubMed ID: 4107104
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the treatment of prostatic adenoma with hydroxyprogesterone caronate].
    Ibba AL
    Osp Ital Chir; 1968; 19(4):427-42. PubMed ID: 4180617
    [No Abstract]   [Full Text] [Related]  

  • 12. Medical treatment of benign nodular prostatic hyperplasia with cyproterone acetate.
    Scott WW; Wade JC
    J Urol; 1969 Jan; 101(1):81-5. PubMed ID: 4178189
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormonal treatment of prostatic hypertrophy with special reference to the usefulness of gestagens].
    Musierowicz A
    Wiad Lek; 1974 Nov; 27(22):1985-8. PubMed ID: 4140619
    [No Abstract]   [Full Text] [Related]  

  • 14. Gestronol hexanoate (SH582) and benign prostatic hypertrophy.
    Pitchford AG
    Proc R Soc Med; 1972 Feb; 65(2):128-9. PubMed ID: 4117436
    [No Abstract]   [Full Text] [Related]  

  • 15. Nonoperative management of senile prostatic hyperplasia.
    Fam A
    Int Surg; 1971 Oct; 56(4):252-9. PubMed ID: 4106484
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of hydroxyprogesterone caproate in the treatment of benign prostatic hyperplasia.
    Jacobs D; Harper JM; Politano VA
    South Med J; 1967 Nov; 60(11):1174-6. PubMed ID: 4168673
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of 17-alpha-hydroxy-19-norprogesterone acaproate (SH-582) on prostatic hypertrophy with special reference to estimation of size of the prostate by means of ultrasonotomography].
    Watanabe H; Kaiho H; Takahashi H; Kato T; Shima M
    Hinyokika Kiyo; 1970 Sep; 16(9):438-45. PubMed ID: 4097357
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of prostatic hypertrophy with progestational steroid (gestonorone caproate)].
    Tanaka H; Fukushige M; Shiraishi T
    Hinyokika Kiyo; 1970 Sep; 16(9):531-50. PubMed ID: 4097365
    [No Abstract]   [Full Text] [Related]  

  • 19. Refractoriness of prostatism to hydroxyprogesterone capronate (delalutin) therapy.
    Weinberg SR
    J Urol; 1968 Jul; 100(1):57-8. PubMed ID: 4173080
    [No Abstract]   [Full Text] [Related]  

  • 20. [On drug therapy of prostatic hypertrophy].
    Rieben W
    Praxis; 1967 Jul; 56(30):1042-7. PubMed ID: 4180980
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.